Filing Details

Accession Number:
0001209191-20-041784
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-08 17:27:32
Reporting Period:
2020-07-07
Accepted Time:
2020-07-08 17:27:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673776 H Steven Stein 1801 Augustine Cut-Off
Wilmington DE 19803
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-07 3,381 $88.68 104,131 No 4 M Direct
Common Stock Disposition 2020-07-07 3,381 $110.04 100,750 No 4 S Direct
Common Stock Acquisiton 2020-07-07 7,495 $88.68 108,245 No 4 M Direct
Common Stock Disposition 2020-07-07 7,495 $110.04 100,750 No 4 S Direct
Common Stock Disposition 2020-07-07 3,283 $107.99 97,467 No 4 S Direct
Common Stock Disposition 2020-07-08 610 $108.56 96,857 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2020-07-07 3,381 $0.00 3,381 $88.68
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-07-07 7,495 $0.00 7,495 $88.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-03-02 No 4 M Direct
0 2015-03-02 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  3. Represents weighted average sale price. Actual sale prices ranged from $110.00 - $110.07.
  4. Represents weighted average sale price. Actual sale prices ranged from $107.04 - $108.79.
  5. This includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  6. Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years